Emergency department utilisation by vulnerable paediatric populations during the COVID-19 pandemic

John A Cheek1,2,3, Simon S Craig4,5, Adam West4,5

  • 1Emergency Department, The Royal Children's Hospital, Melbourne, Victoria, Australia.

Insights

During the COVID-19 pandemic, paediatric emergency department (ED) attendances decreased overall, but mental health and neonatal cases increased, suggesting vulnerable children sought care elsewhere due to service disruptions.

Area of Science:

  • Pediatrics
  • Public Health
  • Epidemiology

Background:

  • The COVID-19 pandemic led to significant disruptions in community-based health services.
  • Changes in service availability may have impacted healthcare-seeking behaviors for pediatric populations.

Purpose of the Study:

  • To evaluate the effect of altered community services on pediatric emergency department (ED) attendances.
  • To analyze trends in ED visits for mental health issues and neonates during the pandemic.

Main Methods:

  • Comparative analysis of total ED presentations, mental health diagnoses, and neonatal presentations.
  • Data collected from four hospitals in Victoria, comparing early pandemic stages with the previous year (2019).

Main Results:

  • A 47.2% decrease in overall pediatric ED presentations was observed.
  • A 35% increase in mental health diagnoses and a 2% increase in neonatal presentations occurred during the pandemic.

Conclusions:

  • Disruptions to community services during the pandemic appear to have displaced vulnerable pediatric patients.
  • Increased ED attendances for mental health and neonatal issues suggest unmet needs and a shift in care-seeking patterns.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
131
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
153
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
176
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
148
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
113
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
181